Search
Now showing items 1-6 of 6
Modifying Diet and Exercise in Multiple Sclerosis: A Pilot Study
(2021)
Background: Modest weight loss can have significant health benefits and reduce the risk of developing chronic health comorbidities (Van Gaal et al., 1997). It remains unclear whether weight loss in individuals with multiple ...
Mechanisms of Action in Motivational Interviewing
(2020)
Despite the demonstrated efficacy of disease modifying therapies (DMT), many MS patients (~ 40%) stop using DMT within 3 years of starting. A cross-over randomized controlled trial demonstrated that a theoretically based motivational interviewing...
Cognition, Fatigue, and Health-related Quality of Life in Multiple Sclerosis: Exploring the Role of Polypharmacy and Anticholinergic Medication Burden
(2022)
OBJECTIVE: Recent evidence suggests that polypharmacy, or the daily use of multiple medications, is common among individuals with multiple sclerosis (MS). Some medications have anticholinergic properties that increase risk ...
A Double-Blind Randomized Intervention to Reduce Distress from Perceived Cognitive Impairment in Multiple Sclerosis
(University of Missouri -- Kansas City, 2019)
OBJECTIVE: Up to 65% of patients with multiple sclerosis (MS) experience cognitive impairment.
However, patients frequently overestimate the extent of their cognitive dysfunction, reducing their
overall quality of life. ...
Beliefs about the Impact of Excess Body Weight on Biopsychosocial Functioning in Multiple Sclerosis Patients
(University of Missouri--Kansas City, 2017)
Background: Recent research indicates that obesity may exacerbate certain symptoms
of Multiple Sclerosis (MS). Nevertheless, little research has examined patients’ perceptions
of how obesity may impact their MS symptoms. ...
Theory of Mind in Multiple Sclerosis: Disease Subtype Differences and Association with Measures of Social Functioning
(2015-08-11)
Theory of mind (ToM) allows a person to make inferences about the mental and
emotional states of others. Generally, people with multiple sclerosis (MS) perform more
poorly on ToM tests than neurologically intact controls. ...